Metabolic adaptations of inflammatory macrophages govern ferroptosis susceptibility via the GCH1-BH4-iNOS axis

Julia Sauer1,2, Patricia P Ogger3, Jasmina Dukic1

  • 1Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany.

Insights

Inflammatory macrophages use distinct pathways, including the GTP cyclohydrolase 1 (GCH1)-tetrahydrobiopterin (BH4) axis, to resist self-inflicted oxidative stress and avoid ferroptosis. This protection is reversible and can be therapeutically targeted.

Area of Science:

  • Cell Biology
  • Immunology
  • Metabolic Pathways

Background:

  • Macrophages in inflammatory environments face significant oxidative stress from producing reactive oxygen and nitrogen species.
  • This oxidative stress can lead to ferroptotic cell death, a regulated form of necrosis.

Purpose of the Study:

  • To investigate the distinct redox-protective mechanisms employed by inflammatory macrophages.
  • To identify key pathways governing macrophage ferroptosis resistance.

Main Methods:

  • Utilized lipopolysaccharide (LPS) and interferon-gamma (IFN-γ) to activate macrophages.
  • Investigated the roles of the GTP cyclohydrolase 1 (GCH1)-tetrahydrobiopterin (BH4) pathway and inducible nitric oxide synthase (iNOS) in macrophage survival.

Main Results:

  • LPS-activated macrophages (M(LPS)) depend on the GCH1-BH4 pathway for ferroptosis resistance.
  • LPS + IFN-γ-activated macrophages (M(LPS-IFN-γ)) primarily rely on nitric oxide produced by iNOS, with BH4 acting suppressively in its absence.
  • A novel GCH1-BH4-iNOS axis dictates macrophage ferroptosis susceptibility.
  • The protective phenotype is reversible upon removal of inflammatory stimuli.

Conclusions:

  • Inflammatory macrophages exhibit context-dependent metabolic adaptations to survive oxidative stress and avoid ferroptosis.
  • The GCH1-BH4-iNOS axis represents a crucial, targetable mechanism for modulating macrophage ferroptosis resistance in therapeutic strategies.